Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Pacira BioSciences, Inc. (PCRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/10/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/04/2023 |
4
| WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 509 shares
@ $34.875, valued at
$17.8k
|
|
| 08/02/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,950 shares
@ $0
Granted 27,500 options to buy
@ $38.74, valued at
$1.1M
|
|
| 06/16/2023 |
4
| Williams Kristen Marie (Chief Administrative Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,950 shares
@ $0
Sold 6,467 shares
@ $37.03, valued at
$239.5k
Granted 27,500 options to buy
@ $38.74, valued at
$1.1M
|
|
| 06/16/2023 |
4
| STACK DAVID M (CEO and Chairman) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 32,700 shares
@ $0
Granted 245,400 options to buy
@ $38.74, valued at
$9.5M
|
|
| 06/16/2023 |
4
| Riker Lauren Bullaro (Senior Vice President, Finance) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Sold 586 shares
@ $37.47, valued at
$22k
Sold 5,773 shares
@ $38.52, valued at
$222.4k
Sold 7 shares
@ $39.01, valued at
$273.1
Granted 25,000 options to buy
@ $38.74, valued at
$968.5k
|
|
| 06/16/2023 |
4
| Reinhart Charles A. III (CFO) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 22,500 options to buy
@ $38.74, valued at
$871.7k
|
|
| 06/16/2023 |
4
| PACE GARY W (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| GAUGLER DARYL (COO) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 25,000 options to buy
@ $38.74, valued at
$968.5k
|
|
| 06/16/2023 |
4
| Froimson Mark (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| CHRISTIE CHRISTOPHER (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/12/2023 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 15,000 shares
@ $37.04, valued at
$555.6k
Exercised 15,000 options to buy
@ $29.9, valued at
$448.5k
|
|
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,779 shares
@ $38.991, valued at
$69.4k
Sold 1,857 shares
@ $37.865, valued at
$70.3k
|
|
| 06/07/2023 |
4
| Williams Kristen Marie (Chief Administrative Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,301 shares
@ $38.991, valued at
$50.7k
Sold 1,357 shares
@ $37.865, valued at
$51.4k
|
|
|
|
|